Immune thrombocytopenia during the COVID-19 pandemic
- PMID: 33855698
- PMCID: PMC8251163
- DOI: 10.1111/bjh.17457
Immune thrombocytopenia during the COVID-19 pandemic
Conflict of interest statement
EL, XL and MH have no disclosures. JBB has served on advisory boards and/or consulted for Amgen, Novartis, Dova, Rigel, UCB, Argenx, Momenta, Regeneron, RallyBio, and CSL‐Behring.
Similar articles
-
COVID-19 related immune hemolysis and thrombocytopenia.J Med Virol. 2021 Feb;93(2):1164-1170. doi: 10.1002/jmv.26402. Epub 2020 Aug 16. J Med Virol. 2021. PMID: 32776538 Free PMC article. Review.
-
Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor.Cancer Invest. 2021 Mar;39(3):217-218. doi: 10.1080/07357907.2020.1871485. Epub 2021 Jan 14. Cancer Invest. 2021. PMID: 33399484 No abstract available.
-
Evans syndrome and immune thrombocytopenia in two patients with COVID-19.J Med Virol. 2021 May;93(5):2642-2644. doi: 10.1002/jmv.26906. Epub 2021 Mar 9. J Med Virol. 2021. PMID: 33634495 Free PMC article. No abstract available.
-
Treatment patterns and outcomes in management of solid cancer patients suffering from thrombocytopenia in Penang hospital.Asian Pac J Cancer Prev. 2011;12(11):2841-5. Asian Pac J Cancer Prev. 2011. PMID: 22393951
-
COVID-19 presenting with immune thrombocytopenia: A case report and review of the literature.J Med Virol. 2021 Jan;93(1):43-45. doi: 10.1002/jmv.26138. Epub 2020 Jun 29. J Med Virol. 2021. PMID: 32497344 Free PMC article. Review. No abstract available.
Cited by
-
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.Infect Drug Resist. 2022 May 31;15:2723-2728. doi: 10.2147/IDR.S360238. eCollection 2022. Infect Drug Resist. 2022. PMID: 35668857 Free PMC article.
-
Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.J Thromb Haemost. 2022 Jun;20(6):1476-1484. doi: 10.1111/jth.15704. Epub 2022 Apr 5. J Thromb Haemost. 2022. PMID: 35313390 Free PMC article.
-
Immune Thrombocytopenia Purpura Associated With COVID-19 Infection: A Challenging Diagnosis and Management.Cureus. 2023 Oct 21;15(10):e47433. doi: 10.7759/cureus.47433. eCollection 2023 Oct. Cureus. 2023. PMID: 38021595 Free PMC article.
-
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.Haematologica. 2022 Sep 1;107(9):2018-2036. doi: 10.3324/haematol.2021.279513. Haematologica. 2022. PMID: 35708136 Free PMC article.
-
Immune thrombocytopenia in the setting of acute SARS-CoV-2 infection.BMJ Case Rep. 2023 Jun 29;16(6):e254352. doi: 10.1136/bcr-2022-254352. BMJ Case Rep. 2023. PMID: 37385718 Free PMC article.
References
-
- Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013;121(14):2596–606. - PubMed
-
- Bussel JCD, Cooper N, Dunbar C, Michel M, Rodeghiero F. COVID‐19 and ITP: Frequently Asked Questions. https://www.hematology.org/covid‐19/covid‐19‐and‐itp2020 [updated 2020, November 18].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical